Bevacizumab (anti-VEGF-A monoclonal antibody) reduces osteoarthritis severity and weight-bearing pain in a rabbit model of osteoarthritis induced by anterior cruciate ligament transection [50,51]. The gene discussed is VEGFA; the disease is osteoarthritis.